Research finds new Rx target for childhood cancer
Research led by Michael Lan, Ph.D., Professor of Pediatrics and Genetics at LSU Health New Orleans School of Medicine, found that a compound named 5'-iodotubercidin (5'-IT) suppresses the growth of neuroblastoma cells and identified a potential new therapeutic approach for the disease.
Read more: https://medicalxpress.com/news/2019-04-rx-childhood-cancer.html